Goodrx Holdings Inc
NASDAQ:GDRX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.15
9.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Goodrx Holdings Inc
Wall Street
Price Targets
GDRX Price Targets Summary
Goodrx Holdings Inc
According to Wall Street analysts, the average 1-year price target for
GDRX
is 7.41 USD
with a low forecast of 4.55 USD and a high forecast of 10.5 USD.
GDRX Last Price Targets
Goodrx Holdings Inc
The latest public price target was made on Jun 10, 2024 by
Craig Hettenbach
from
Morgan Stanley
,
who expects
GDRX
stock to
rise by 114%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Craig Hettenbach
Morgan Stanley
|
9.5
USD
Upside 114% |
6 months ago
Jun 10, 2024
|
GoodRx price target raised to $9.50 from $7 at Morgan Stanley
TheFly
|
Mark Mahaney
RBC Capital
|
10
USD
Upside 125% |
6 months ago
May 23, 2024
|
RBC Capital Upgrades GoodRx Holdings Inc. (GDRX) to Outperform
StreetInsider
|
Aaron Kessler
Raymond James
|
10
USD
Upside 125% |
7 months ago
May 16, 2024
|
Raymond James Upgrades GoodRx Holdings Inc. (GDRX) to Outperform
StreetInsider
|
Stephanie Davis
Barclays
|
9
USD
Upside 103% |
7 months ago
May 16, 2024
|
Barclays Reiterates Overweight Rating on GoodRx Holdings Inc. (GDRX)
StreetInsider
|
Scott Schoenhaus
KeyBanc
|
9
USD
Upside 103% |
8 months ago
Apr 10, 2024
|
KeyBanc Upgrades GoodRx Holdings Inc. (GDRX) to Overweight
StreetInsider
|
|
Scott Schoenhaus
BOCOM International Holdings Company
|
9
USD
Upside 103% |
8 months ago
Apr 10, 2024
|
GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings
Benzinga
|
Stan Berenshteyn
Wells Fargo
|
10
USD
Upside 125% |
8 months ago
Mar 25, 2024
|
Wells Fargo Upgrades GoodRx Holdings Inc. (GDRX) to Overweight
StreetInsider
|
Eric Sheridan
Goldman Sachs
|
3
USD
Downside 32% |
1 year ago
Nov 13, 2023
|
HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga
|
| Price Target | 9 USD |
| Upside/Downside | 103% |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GDRX's stock price target?
Price Target
7.41
USD
According to Wall Street analysts, the average 1-year price target for
GDRX
is 7.41 USD
with a low forecast of 4.55 USD and a high forecast of 10.5 USD.
What is Goodrx Holdings Inc's Revenue forecast?
Projected CAGR
7%
For the last 6 years the
compound annual growth rate for
Goodrx Holdings Inc's revenue is
30%.
The projected
CAGR
for the next 4 years is
7%.
You don't have any saved screeners yet
